L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review.
Wenbo WangDa PanQi LiuXiangjun ChenShaokang WangPublished in: Nutrients (2024)
In summary, LC has demonstrated favorable therapeutic effects in the management of HE, Alzheimer's disease (AD), carpal tunnel syndrome (CTS), CD, migraine, neurofibromatosis (NF), PNSDs, RS, and stroke. However, its efficacy appears to be relatively limited in conditions such as ALS, ataxia, attention deficit hyperactivity disorder (ADHD), depression, chronic fatigue syndrome (CFS), Down syndrome (DS), and sciatica.
Keyphrases
- attention deficit hyperactivity disorder
- autism spectrum disorder
- working memory
- sleep quality
- signaling pathway
- atrial fibrillation
- mental health
- depressive symptoms
- cognitive decline
- oxidative stress
- early onset
- lps induced
- cerebral ischemia
- case report
- nuclear factor
- simultaneous determination
- inflammatory response
- combination therapy
- high resolution
- brain injury
- replacement therapy